American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2134)
  2. Solid Tumor Oncology Division (1785)
  3. GSK Faculty (1633)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (779)
  6. Department of Pathology and Laboratory Medicine (721)
  7. Human Oncology and Pathogenesis Program (682)
  8. Surgery (644)
  9. Breast Medicine Service (610)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (581)
Search Within
Formats
  1. Journal Article (2033)
  2. Meeting Abstract (1999)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2134)
  2. Solid Tumor Oncology Division (1785)
  3. GSK Faculty (1633)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (779)
  6. Department of Pathology and Laboratory Medicine (721)

More Groups

People
  1. David Solit (175)
  2. Marc Ladanyi (157)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (37)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2703)
  2. Clinical Cancer Research (1432)

Results (4135)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer cells hijack physiologic metabolic signals to seed liver metastasis
    Editorial

    Rettig, A. R.; Ganesh, K.
    Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase II DORA study of olaparib with or without durvalumab as a chemotherapy-free maintenance strategy in platinum-pretreated advanced triple-negative breast cancer
    Journal Article

    Tan, T. J.; Sammons, S.; Im, Y. H.; She, L.; Mundy, K.; Bigelow, R.; Traina, T. A.; Anders, C.; Yeong, J.; Renzulli, E.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer
    Journal Article

    Dorff, T.; Horvath, L. G.; Autio, K.; Bernard-Tessier, A.; Rettig, M. B.; Machiels, J. P.; Bilen, M. A.; Lolkema, M. P.; Adra, N.; Rottey, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Trastuzumab and pertuzumab in patients with non-breast/gastroesophageal HER2-amplified tumors: Results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol J
    Journal Article

    Connolly, R. M.; Wang, V.; Hyman, D. M.; Grivas, P.; Mitchell, E. P.; Wright, J. J.; Sharon, E.; Gray, R. J.; McShane, L. M.; Rubinstein, L. V.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Supporting convergence science
    Editorial

    Iacobuzio-Donahue, C. A.
    Cancer Research (2024)

    Fulltext@MSK | Save
  • The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
    Journal Article

    Halabi, S.; Guo, S.; Park, J. J.; Nanus, D. M.; George, D. J.; Antonarakis, E. S.; Danila, D. C.; Szmulewitz, R. Z.; McDonnell, D. P.; Norris, J. D.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Objective analysis and clinical significance of the spatial tumor-infiltrating lymphocyte patterns in non-small cell lung cancer
    Journal Article

    Lopez de Rodas, M.; Wang, Y.; Peng, G.; Gu, J.; Mino-Kenudson, M.; Riess, J. W.; Velcheti, V.; Hellmann, M.; Gainor, J. F.; Zhao, H.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase I study of ORIC-101, a glucocorticoid receptor antagonist, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer progressing on enzalutamide
    Journal Article

    Abida, W.; Hahn, A. W.; Shore, N.; Agarwal, N.; Sieber, P.; Smith, M. R.; Dorff, T.; Monk, P.; Rettig, M.; Patel, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • PD-1 expression on intratumoral regulatory T cells is associated with lack of benefit from anti-PD-1 therapy in metastatic clear-cell renal cell carcinoma patients
    Journal Article

    Denize, T.; Jegede, O. A.; Matar, S.; Al Ahmar, N.; West, D. J.; Walton, E.; Bagheri, A. S.; Savla, V.; Laimon, Y. N.; Gupta, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase Ib study of the DNA-PK inhibitor peposertib combined with neoadjuvant chemoradiation in patients with locally advanced rectal cancer
    Journal Article

    Romesser, P. B.; Capdevila, J.; Garcia-Carbonero, R.; Philip, T.; Martos, C. F.; Tuli, R.; Rodriguez-Gutierrez, A.; Kuipers, M.; Becker, A.; Coenen-Stass, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: